EUROPEAN HIV CLINICAL FORUM 2020: OPTIMIZING TREATMENT
The European HIV Clinical Forum 2020 provides an independent scientific program involving the world’s leading experts and is specifically designed for the European HIV healthcare professionals with the focus on optimizing treatment for their patients. The meeting is scheduled prior to the 18th European meeting on HIV & Hepatitis in Paris, France, which will allow healthcare professionals to combine both meetings in one trip thus limiting travel time and the number of days away from the clinic.
This program will feature challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and the sharing of knowledge within the HIV-treating community in Europe. The program will end with a networking reception for community building; thus, providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.
The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management, where they can share their clinical experience and present the results from their ongoing and completed cohorts/ research programs.
Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects.
HAVE A LOOK AT THE PREVIOUS MEETING'S PRESENTATIONS AND CONTENT HERE:
EUROPEAN HIV CLINICAL FORUM 2019
Last year's edition of the European HIV Clinical Forum was organized on 5 November 2019, prior to the EACS - 17th European AIDS Conference. The forum attracted nearly 80 participants, from 23 European countries. The focus of last year's meeting was on important clinical developments and updates on ongoing and new trials in the field of optimizing treatment. The program featured several invited lectures, abstracts and clinical cases discussions. The day ended with a social get together over drinks, providing a unique opportunity to meet colleagues from different countries.
Feedback from the participants showed that the workshop was very well received. All off the respondents indicated that the lectures have increased their knowledge, 98% agreed that the program was beneficial for the clinical management of their patients, and 97% reported that they intend to incorporate the new information from the workshop into the care of their patients.
FINAL PROGRAM - TUESDAY,27 OCTOBER 2020
Welcome, Introductions, and Goals
Anne-Genevieve Marcelin, PharmD, PhD, Hôpital Pitié-Salpétrière, France
Clinical update: Oral therapies for drug naïve and suppressed patients
Gary Rubin, MD - University of Toronto, Canada
Clinical update: Injectable drug regimens
Charles Flexner, MD - Johns Hopkins University School of Medicine, United States
Clinical update: Highly treatment experienced patients
Michael Kozal, MD - Yale University, United States
Virology: Implications for Resistance
Diane Descamps, MD, PhD - Hopital Bichat-claude Bernard, France
Virology/Immunology: Implications for Reservoirs / Cure
Mathias Lichterfeld, MD, PhD - Brigham and Women’s Hospital, Harvard Medical School, United States
Pharmacology: Implications for poor adherence and sanctuary sites Charles Flexner, MD - Johns Hopkins University School of Medicine, United States
Virological and Pharmacological monitoring: How and how often? Andrea Calcagno, MD, DTM&H - University of Torino, Italy
Management of drug-drug interactions and poor adherence
Kimberly Scarsi, PharmD, MS - University of Nebraska Medical Center, United States
Financial considerations in oral versus parenteral HIV therapy
Andrew Hill, MD - Liverpool University, United Kingdom
Pep Coll, MD - AIDS Research Institute-IrsiCaixa, Spain
Christoph Boesecke, MD - Universitätsklinikum Bonn, Germany
David Jilich, MD - Hospital Na Bulovce, Czech Republic
Summary and Closure of Program
Anton Pozniak, MD, FRCP - Chelsea and Westminster Hospital, United Kingdom
Jonathan M. Schapiro, MD
National Hemophilia Center Sheba Medical Center
Charles Boucher, MD, PhD
Erasmus Medical Center
The European HIV Clinical Forum 2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 4 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
The European HIV Clinical Forum 2020 is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
International Association of Providers of AIDS Care (IAPAC)
We trust that the following information (in alphabetical order) will assist you in organizing your registration and stay to the European HIV Clinical Forum 2020: Optimizing Treatment.
Certificate of Attendance
A certificate of attendance will be sent by e-mail after the forum meeting in the following week.
This forum meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from the meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending this forum meeting.
The official language of this meeting is English.
Liability and Insurance
By registering for this forum meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
An official program and speaker's bios will be sent by e-mail one day prior to the virtual forum meeting.
Payment and Procedure of Online Registration
Registration is free of charge for all healthcare practitioners. You will get a confirmation of the registration within 1-5 business days. If you did not receive a confirmation, please contact the Organizing Secretariat by e-mail: Dagmar@vironet.com.
For any inquiries or questions, please contact Virology Education at email@example.com or call +31 (0)30 230 7146. You can also contact us by filling out the contact form.